Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years

Bisphosphonate (BP) therapy has been associated with atypical femur fracture (AFF). However, the threshold of treatment duration leading to increased AFF risk is unclear. In a retrospective cohort of older wom...

Source: BMC Musculoskeletal Disorders - December 3, 2020 Category: Orthopaedics Authors: Joan C. Lo, Romain S. Neugebauer, Bruce Ettinger, Malini Chandra, Rita L. Hui, Susan M. Ott, Christopher D. Grimsrud and Monika A. Izano Tags: Research article Source Type: research